Septién HI, Anzures GA, Urrutia ML, Saltigeral SP

Idioma: Español
Referencias bibliográficas: 22
Paginas: 22-28
Archivo PDF: 96.08 Kb.

RESUMEN

En este trabajo se informa de las vacunas disponibles en el comercio para la prevención de enfermedades que inciden en los adolescentes: indicaciones, dosis, eficacia y aquello necesario para saber para su aplicación en los jóvenes.

REFERENCIAS (EN ESTE ARTÍCULO)

1. CDC. Recommendations and reports MMWR. 2006; 55 (Dec.1): 55/No. RR-15.

2. Sociedad Latinoamericana de Infectología Pediátrica. Manual de vacunas de Latinoamérica. Vacunaciones Sistemáticas. 2005: Capítulo 8: 278-93. http://www.slipe.org/articulos_manual_ vacunas.asp

3. Quevedo L. Vacunas en Pediatría. 2a ed. Bogotá: Editorial Panamericana 2004.

4. CDC. Weekly Quick Guide. Recommended immunizations schedules for persons aged 0-18 years. United States 2007. 2007; 55: 51-52.

5. Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Hepatitis B. In: Red Book 2006 (27th ed) Elk Grove Village, IL: American Academy of Pediatrics, 2006: 179-81.

6. CDC. Measles in United States in 2005. MMWR 2006; 55: 1348-51.

7. Committee on Infectious Diseases. Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007; 120: 221-31.

8. Secretaría de Salud. SUIVE (Sistema Único de Vigilancia Epidemiológica) 2006. Boletín Epidemiológico Nacional 2006.

9. Secretaría de Salud de México. Vacunación Universal y Semanas Nacionales de Salud. Lineamientos Generales 2007. http://portal.salud.gob.mx/.

10. Kent ZR, Middleton DB, Kimmel SR. Vaccines across the life span. J Family Practice 2007; 56(2): 8-10.

11. CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46(RR-7): 1-25.

12. CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis. 2005. CDC Guidelines. MMWR 2005; 54(RR-14): 1-16.

13. CDC. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006; 55(RR-3): 1-43.

14. De Carvalho AP, Pereira EMC. Acellular pertusis vaccine for adolescents. Jornal Pediatr (Rio) 2006: 82(Supl): S15-S23. www.jped.com.br

15. CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005; 54(RR-7).

16. CDC. Improved supply of meningococcal conjugate vaccine, recommendation to resume vaccination of children aged 11-12 years. MMWR 2006; 55: 1177.

17. Cintra O, Rey LC. Safety, immunogenicity and efficacy of influenza vaccine in children. Jornal Pediatr (Rio) 2006; 82(Supl): S83-S88. www.jped.com.br

18. Epidemiology and prevention of vaccine-preventable diseases. Pink Book. 10th ed. February 2007. http://www.cdc.gov/vaccines/pubs/pinkbook/pink-chapters.htm

19. Mascareñas A. Virus del papiloma humano (VPH). Rev Enf Inf Ped 2007; 80(Supl 2): 1-7.

20. American Cancer Society. Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors CA. Cancer J Clin 2007; 57: 7-28.

21. Stan L, Nolan T, Sattler C, Barr E, Giacoletti K, Marchant CD. Block et al. Particle vaccine in male and female adolescents and young adult women quadrivalent human papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like. Comparison of the immunogenicity and reactogenicity of a prophylact. Pediatrics 2006; 118: 2135-45.

22. Da Silva LJ, Richtmann R. Vaccines under development: group B streptococcus, herpes-zoster, HIV, malaria and dengue. Jornal Pediatr (Rio) 55: 1562-7 www.jped.com.br